**BACKGROUND:** Fibroblasts are key players for maintaining skin homeostasis and for orchestrating physiological tissue repair. They are present in all the phases of wound healing and their phenotype and function is changed under influence of various cytokines, of which transforming growth factor beta (TGF-β) stands out. TGF-β induces fibroblasts transdifferentiation into myofibroblasts and matrix preservation and deposition.^1^ CB1 receptor activation has been linked with fibrosis and formation of scar tissue in various tissues as in liver and skin.^2,3^ In fatty acid amide hydrolase knock-out mice it has been shown that elevated levels of endocannabinoids may induce skin fibroses in a CB1 dependent manner.^4^ However, it is not known if cannabinoids have an effect in fibrinogenisis due to fibroblast activation or inflammation regulation. The aim of our study is to investigate whether CB1 ligands play a role in activation and differentiation of human fibroblasts.

**MATERIAL and METHODS:** After informed consent, human skin samples were obtained from patients submitted abdominoplasty surgery. In total, samples from nine healthy patients with medium age of 37-years-old (23--51 years). Primary cultures of adult human fibroblasts were obtained from skin samples. Vimentin expression was used to confirm the presence of fibroblasts *in-vitro.* Human fibroblasts were stimulated with TGF-β (10 ng/ml) to induce fibroblasts differentiation and then treated with CB1 ligands (AM251 10μM; ACEA 1μM). *Trypan blue* exclusion test for cell *viability* evaluation was performed. Fibroblasts activation into myofibroblasts was quantified by the expression of alpha smooth muscle actin (α-SMA) using Immunocytochemistry and Western Blotting assays. The significance of differences between means was assessed by Student's unpaired t-test. Values of P \< 0.05 are considered significant.

**RESULTS:** TGF-*β* induces fibroblast activation, measured by a 17-fold increase in the relative protein expression of α-SMA (mean ± SEM.: 17.00 ± 6.1 in optical density). The CB1 agonist ACEA 1μM alone did not change (mean ± SEM.:1.1 ± 0.2) fibroblasts activation neither affected differentiation induced by TGF-*β* (mean ± SEM.: 21.16 ± 7.4). However, TGF-*β* effect was reverted in the presence of both CB1 agonist ACEA 1μM and CB1 antagonist AM251 10 μM (mean ± SEM.: 2.1 ± 0.7). Moreover, the CB1 antagonist alone also reverts TGF-*β* effect (mean ± SEM: 2.2 ± 0.1). Cell viability was not modified after treatment with CB1 agonists and antagonists or stimulation with TGF-*β.*

**CONCLUSION:** Inactivation of cannabinoid receptor CB1 reverts fibroblasts differentiation induced by TGF-*β* in human fibroblasts.
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